Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.87)
# 768
Out of 5,182 analysts
493
Total ratings
43.43%
Success rate
11.63%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Maintains: Buy | $32 → $31 | $15.71 | +97.33% | 17 | Apr 15, 2026 | |
| ACTU Actuate Therapeutics | Maintains: Buy | $20 → $15 | $2.62 | +472.52% | 5 | Apr 13, 2026 | |
| EDAP EDAP TMS | Maintains: Buy | $14 → $10 | $3.42 | +192.40% | 15 | Apr 9, 2026 | |
| RNXT RenovoRx | Reiterates: Buy | $3 | $1.01 | +198.51% | 4 | Apr 8, 2026 | |
| IPHA Innate Pharma | Reiterates: Buy | $5 | $1.59 | +214.47% | 19 | Apr 7, 2026 | |
| PGEN Precigen | Maintains: Buy | $9 → $10 | $4.11 | +143.31% | 15 | Mar 26, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $67 → $60 | $46.34 | +29.48% | 30 | Mar 25, 2026 | |
| OCGN Ocugen | Maintains: Buy | $7 → $10 | $1.85 | +440.54% | 23 | Mar 25, 2026 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $7 | $1.70 | +311.76% | 12 | Mar 24, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterates: Buy | $130 | $95.71 | +35.83% | 6 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $52 | $25.28 | +105.70% | 10 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.5 → $10 | $7.52 | +32.98% | 9 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.50 | +300.00% | 16 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.75 | +128.57% | 16 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $130 | $91.92 | +41.43% | 9 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $4.49 | +256.35% | 15 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $64 | $35.81 | +78.72% | 19 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $18 | $6.31 | +185.26% | 14 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.88 | +175.74% | 16 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.88 | +38.89% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.38 | - | 17 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.95 | +102.53% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $15.87 | +183.55% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $17.35 | +107.49% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $155 | $108.24 | +43.20% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $120.09 | -21.73% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $6.34 | +105.05% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $4.19 | +19.33% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $50 | $3.00 | +1,566.67% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $7.43 | +196.10% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.88 | +241.30% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.37 | +2,865.76% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $2.39 | +527.62% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.69 | +336.36% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.01 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.89 | +85.19% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $5.29 | +523.82% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $5.22 | +2,296.93% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.25 | +238.46% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.66 | +2,921.60% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $8.49 | +6.01% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.84 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.62 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.24 | +1,916.13% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.89 | +28.53% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.95 | +3,967.80% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,250 → $1,000 | $5.69 | +17,474.69% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $23.73 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $15.54 | -61.39% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.49 | +906.71% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $6.52 | +406.13% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $11.55 | -17.75% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $0.79 | +1,770,930.99% | 1 | Mar 5, 2020 |
Vor Biopharma
Apr 15, 2026
Maintains: Buy
Price Target: $32 → $31
Current: $15.71
Upside: +97.33%
Actuate Therapeutics
Apr 13, 2026
Maintains: Buy
Price Target: $20 → $15
Current: $2.62
Upside: +472.52%
EDAP TMS
Apr 9, 2026
Maintains: Buy
Price Target: $14 → $10
Current: $3.42
Upside: +192.40%
RenovoRx
Apr 8, 2026
Reiterates: Buy
Price Target: $3
Current: $1.01
Upside: +198.51%
Innate Pharma
Apr 7, 2026
Reiterates: Buy
Price Target: $5
Current: $1.59
Upside: +214.47%
Precigen
Mar 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $4.11
Upside: +143.31%
Corcept Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $67 → $60
Current: $46.34
Upside: +29.48%
Ocugen
Mar 25, 2026
Maintains: Buy
Price Target: $7 → $10
Current: $1.85
Upside: +440.54%
Pyxis Oncology
Mar 24, 2026
Reiterates: Buy
Price Target: $7
Current: $1.70
Upside: +311.76%
Mirum Pharmaceuticals
Mar 23, 2026
Reiterates: Buy
Price Target: $130
Current: $95.71
Upside: +35.83%
Mar 20, 2026
Maintains: Buy
Price Target: $37 → $52
Current: $25.28
Upside: +105.70%
Mar 19, 2026
Maintains: Buy
Price Target: $4.5 → $10
Current: $7.52
Upside: +32.98%
Mar 13, 2026
Reiterates: Buy
Price Target: $6
Current: $1.50
Upside: +300.00%
Mar 10, 2026
Reiterates: Buy
Price Target: $4
Current: $1.75
Upside: +128.57%
Mar 9, 2026
Maintains: Buy
Price Target: $47 → $130
Current: $91.92
Upside: +41.43%
Mar 9, 2026
Reiterates: Buy
Price Target: $16
Current: $4.49
Upside: +256.35%
Feb 27, 2026
Maintains: Buy
Price Target: $60 → $64
Current: $35.81
Upside: +78.72%
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $6.31
Upside: +185.26%
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $10.88
Upside: +175.74%
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.88
Upside: +38.89%
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $11.38
Upside: -
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $3.95
Upside: +102.53%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $15.87
Upside: +183.55%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $17.35
Upside: +107.49%
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $108.24
Upside: +43.20%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $120.09
Upside: -21.73%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $6.34
Upside: +105.05%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $4.19
Upside: +19.33%
Nov 4, 2025
Assumes: Buy
Price Target: $50
Current: $3.00
Upside: +1,566.67%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $7.43
Upside: +196.10%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.88
Upside: +241.30%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.37
Upside: +2,865.76%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $2.39
Upside: +527.62%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.69
Upside: +336.36%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.01
Upside: -
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.89
Upside: +85.19%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $5.29
Upside: +523.82%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $5.22
Upside: +2,296.93%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $3.25
Upside: +238.46%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.66
Upside: +2,921.60%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $8.49
Upside: +6.01%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.84
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.62
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.24
Upside: +1,916.13%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $3.89
Upside: +28.53%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.95
Upside: +3,967.80%
Aug 10, 2022
Maintains: Buy
Price Target: $1,250 → $1,000
Current: $5.69
Upside: +17,474.69%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $23.73
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $15.54
Upside: -61.39%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.49
Upside: +906.71%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $6.52
Upside: +406.13%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $11.55
Upside: -17.75%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $0.79
Upside: +1,770,930.99%